Last updated: April 20, 2024
Sponsor: Rigshospitalet, Denmark
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bone Diseases
Treatment
Constrained Liner
Dual Mobility
Clinical Study ID
NCT05461313
H-21078128
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed with metastatic bone disease of the hip defined as bone lesions in theproximal femur because of secondary malignant growth of a primary cancer locatedelsewhere or bone lesions in the proximal femur due to hematological malignancies
- Determined eligible for total hip arthroplasty for metastatic bone disease of the hipand is planned to undergo surgery at the study site
- Provides informed consent prior to initiation of any study-specificactivities/procedures
Exclusion
Exclusion Criteria:
- Previous osteosynthesis or endoprosthetic surgery of the ipsilateral hip
- Pelvic reconstruction of the ipsilateral hip
- Total femoral replacement of the ipsilateral femur
- It is not surgically viable to insert an acetabular cup and/or a femoral stem
- Subject is currently or has previously been enrolled in this study
- Subject is incapable of understanding the patient information or unable to provideinformed consent
Study Design
Total Participants: 146
Treatment Group(s): 2
Primary Treatment: Constrained Liner
Phase:
Study Start date:
September 20, 2022
Estimated Completion Date:
July 31, 2026
Study Description
Connect with a study center
Department of Orthopedic Surgery, Rigshospitalet
Copenhagen, 2100
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.